Workflow
新天地：2025年第二次临时股东会决议公告
Henan Newland Pharmaceutical Henan Newland Pharmaceutical (SZ:301277) Zheng Quan Ri Bao Zhi Sheng·2025-09-02 13:10

Group 1 - The company announced that its second extraordinary general meeting of shareholders in 2025 approved the proposal to use part of the raised funds to permanently supplement working capital [1] - The company also approved the proposal regarding the non-operating fund occupation and other related fund transactions for the first half of 2025 [1]